Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
MACROPHAGES-LIKE CELLS INCREASE IN VIVO IN ACTIVE UVEITIS AND RESPOND TO ANTI-INFLAMMATORY TREATMENT
Author Affiliations & Notes
  • Ester Carreño
    Ophthalmology, Hospital Universitario Fundacion Jimenez Diaz, Madrid, Madrid, Spain
  • Piergiorgio Neri
    Cleveland Clinic Abu Dhabi Eye Institute, Abu Dhabi, Abu Dhabi, United Arab Emirates
  • Shaikha Aljneibi
    Cleveland Clinic Abu Dhabi Eye Institute, Abu Dhabi, Abu Dhabi, United Arab Emirates
  • Steven Hay
    Cleveland Clinic Abu Dhabi Eye Institute, Abu Dhabi, Abu Dhabi, United Arab Emirates
  • Hannah Chaudhry
    Cleveland Clinic Abu Dhabi Eye Institute, Abu Dhabi, Abu Dhabi, United Arab Emirates
  • Francesco Pichi
    Cleveland Clinic Abu Dhabi Eye Institute, Abu Dhabi, Abu Dhabi, United Arab Emirates
  • Footnotes
    Commercial Relationships   Ester Carreño Santen, GSK, Active biotech, Allimera, Code C (Consultant/Contractor); Piergiorgio Neri None; Shaikha Aljneibi None; Steven Hay None; Hannah Chaudhry None; Francesco Pichi None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 1446. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ester Carreño, Piergiorgio Neri, Shaikha Aljneibi, Steven Hay, Hannah Chaudhry, Francesco Pichi; MACROPHAGES-LIKE CELLS INCREASE IN VIVO IN ACTIVE UVEITIS AND RESPOND TO ANTI-INFLAMMATORY TREATMENT. Invest. Ophthalmol. Vis. Sci. 2024;65(7):1446.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To highlight the utility of en face swept-source optical coherence tomography angiography (SS-OCTA) in assessing macrophage-like cells (MLCs) on the retinal surface of patients with active uveitis and their response to anti-inflammatory treatment.

Methods : In this prospective, single center study, twenty eyes from active uveitis patients were analyzed using six 6×6 mm macular scans at three timepoints: active inflammation (baseline), clinically improving (T1), and resolved inflammation (T2). MLCs were visualized using 6 consecutive 3μm en face OCT slabs on the inner limiting membrane, and posteriorly registered and averaged to increase the sign to noise ratio. The variation of MLCs number, density and size over time was assessed and MLCs measurements were compared with clinical inflammation grading.

Results : At baseline, MLCs count was significantly higher (552.5) than healthy controls (478.2 MLCs), with a density of 15.3 cells/mm2. MLCs number decreased significantly to 394.8 (p = 0.007) at T1, with a density of 10.9 cells/mm2 (p = 0.007). MLCs size reduced from 979.2 μm2 to 907.2 μm2 at T1 (p = 0.009) and remained stable at T2 (p = 0.3). Correlation coefficients between inflammatory parameters (AC cells and NEI haze) and MLCs count indicated a positive correlation at baseline (r = 0.53), weakening at T1 (r = 0.36), and becoming negative at T2 (r = -0.24).

Conclusions : En face SS-OCTA revealed increased MLCs number and size in active uveitis, likely due to circulating monocyte recruitment. Post-inflammation control, MLC number, size, and density significantly decreased, returning to normal despite residual AC cells or vitreous haze.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

 

A 43-years-old female with panuveitis secondary to multiple sclerosis was scanned at 3 time points while inflammation was being treated with oral prednisolone. Row A shows the MLCs highlighted in red and their progressive decrease in number at the various time-points. Row B shows a color map of the MLCs density and it is clear the decrease in their number from baseline to T1, while T1 to T2 their density remains stable.

A 43-years-old female with panuveitis secondary to multiple sclerosis was scanned at 3 time points while inflammation was being treated with oral prednisolone. Row A shows the MLCs highlighted in red and their progressive decrease in number at the various time-points. Row B shows a color map of the MLCs density and it is clear the decrease in their number from baseline to T1, while T1 to T2 their density remains stable.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×